VIMPAT 50 mg, film-coated tablet 14 tablets
Active ingredients: Lacosamide
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet14 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- VIMPAT 50 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC PVDC aluminium de 14 comprimé(s)
- Marketing authorisation holder
- UCB PHARMA BELGIQUE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 12 Jul 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62377079CIP73882957CIP133400938829570Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LACOSAMIDEcomprimé | 50 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.